The next generation sequencing (NGS) sample preparation market is anticipated to value over USD 2 billion with a CAGR of over 17% during the forecast period 2019-2026. Next generation sequencing (NGS) is a parallel sequencing method that helps build up a whole human genome rapidly. The technique is used for research, diagnosis, targeted treatment, etc. The NGS sample preparation is an emerging market sector because of its wide range of applications and further research scope. This is the key driver impacting market growth. On the basis of products, the market is divided into reagents and consumables, library preparation and target enrichment. The library preparation and target enrichment are anticipated to contribute as a major part of the market. This is because both the segments are funded by government and non-government bodies due to its scope in research and biopharmaceuticals. These segments are anticipated to impact market growth. Based on the applications, the diagnosis of cancer is one of the major drivers which impact the market growth of NGS sample preparation. The rise in the risk and number of cancer patients and the awareness for its preventive measures are increasing the demand for NGS sample preparation market. Research centres are estimated to have a large share in the market of NGS sample preparation as they get more attention by several funding organizations so that new advancements get promoted. Further projects in the NGS sample preparation are estimated to boost the market growth and influence the CAGR positively. Inclination towards research in NGS sample preparation and the favorable regulatory authorities are estimated to be the drivers in the growth of the market in North America. The Asia Pacific also has focused on new advancements in NGS sample preparation market due to rising incidence and awareness of genetic disorders. Key players in the NGS sample preparation market are Agilent Technologies, Inc. Becton, Dickinson and Company Beckman Coulter (A Subsidiary of Danaher) F. Hoffmann-La Roche AG and so on. Agilent Technologies is anticipated to have a major market share. It has a range of advanced NGS assays for diagnosis of cancer, target enrichment probes, NGS software, NGS quality control, and so on. The availability of these facilities by Agilent Technologies is the key factor driving its market growth in NGS sample preparation across the globe. Competitive Landscape: Agilent Technologies has provided NGS assays for the detection of somatic cancer and is expected to be the key factor. Agilent Technologies has a target enrichment probe that targets 151 key genes associated with a wide range of cancers. FutureWise Key Takeaways: Drug discovery based on NGS sample preparation More focus on target enrichment techniques Global Next Generation Sequencing (NGS) Sample Preparation Market Segmentation: By Product: Reagents and consumables market by workflow Library preparation and target enrichment market by technology By Applications: Diagnostic applications Drug discovery Agriculture and animal research Other applications By End User: Academic institutes and research centres Hospitals and Clinics Pharmaceutical and biotechnology companies Other end users By Region: North America Europe Asia Pacific Rest of the world Objectives of the Study: To provide with an exhaustive analysis on the next generation sequencing (NGS) sample preparation market by products, by applications, by end user and by region. To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe and the rest of the world. To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies. Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com
The next generation sequencing (NGS) sample preparation market is anticipated to value over USD 2 billion with a CAGR of over 17% during the forecast period 2019-2026.
Next generation sequencing (NGS) is a parallel sequencing method that helps build up a whole human genome rapidly. The technique is used for research, diagnosis, targeted treatment, etc. The NGS sample preparation is an emerging market sector because of its wide range of applications and further research scope. This is the key driver impacting market growth.
On the basis of products, the market is divided into reagents and consumables, library preparation and target enrichment. The library preparation and target enrichment are anticipated to contribute as a major part of the market. This is because both the segments are funded by government and non-government bodies due to its scope in research and biopharmaceuticals. These segments are anticipated to impact market growth.
Based on the applications, the diagnosis of cancer is one of the major drivers which impact the market growth of NGS sample preparation. The rise in the risk and number of cancer patients and the awareness for its preventive measures are increasing the demand for NGS sample preparation market.
Research centres are estimated to have a large share in the market of NGS sample preparation as they get more attention by several funding organizations so that new advancements get promoted. Further projects in the NGS sample preparation are estimated to boost the market growth and influence the CAGR positively.
Inclination towards research in NGS sample preparation and the favorable regulatory authorities are estimated to be the drivers in the growth of the market in North America. The Asia Pacific also has focused on new advancements in NGS sample preparation market due to rising incidence and awareness of genetic disorders.
Key players in the NGS sample preparation market are Agilent Technologies, Inc. Becton, Dickinson and Company Beckman Coulter (A Subsidiary of Danaher) F. Hoffmann-La Roche AG and so on. Agilent Technologies is anticipated to have a major market share. It has a range of advanced NGS assays for diagnosis of cancer, target enrichment probes, NGS software, NGS quality control, and so on. The availability of these facilities by Agilent Technologies is the key factor driving its market growth in NGS sample preparation across the globe.
Competitive Landscape:
FutureWise Key Takeaways:
Global Next Generation Sequencing (NGS) Sample Preparation Market Segmentation:
By Product:
By Applications:
By End User:
By Region:
Objectives of the Study:
Get unlimited analyst support and customise this study further to your requirements, contact sales@futurewiseresearch.com
OR